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Abstract
Introduction: Functional imaging studies of addiction following protracted abstinence have not been systematically
conducted to look at the associations between severity of use of different drugs and brain dysfunction. Findings from such
studies may be relevant to implement specific interventions for treatment. The aim of this study was to examine the
association between resting-state regional brain metabolism (measured with 18F-fluorodeoxyglucose Positron Emission
Tomography (FDG-PET) and the severity of use of cocaine, heroin, alcohol, MDMA and cannabis in a sample of
polysubstance users with prolonged abstinence from all drugs used.
Methods: Our sample consisted of 49 polysubstance users enrolled in residential treatment. We conducted correlation
analyses between estimates of use of cocaine, heroin, alcohol, MDMA and cannabis and brain metabolism (BM) (using
Statistical Parametric Mapping voxel-based (VB) whole-brain analyses). In all correlation analyses conducted for each of the
drugs we controlled for the co-abuse of the other drugs used.
Results: The analysis showed significant negative correlations between severity of heroin, alcohol, MDMA and cannabis use
and BM in the dorsolateral prefrontal cortex (DLPFC) and temporal cortex. Alcohol use was further associated with lower
metabolism in frontal premotor cortex and putamen, and stimulants use with parietal cortex.
Conclusions: Duration of use of different drugs negatively correlated with overlapping regions in the DLPFC, whereas
severity of cocaine, heroin and alcohol use selectively impact parietal, temporal, and frontal-premotor/basal ganglia regions
respectively. The knowledge of these associations could be useful in the clinical practice since different brain alterations
have been associated with different patterns of execution that may affect the rehabilitation of these patients.
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Introduction
Drug addiction has been associated with neuroadaptations in
brain systems involved in motivation, memory and executive
control [1]. Functional neuroimaging studies have revealed that
the use of different classes of drugs is associated with dysfunctions
in a range of overlapping brain regions including ventromedial
and dorsolateral prefrontal cortex (DLPFC), anterior cingulate
cortex, inferior frontal gyrus, insula, amygdala, basal ganglia and
cerebellum [2]. These dysfunctions may explain the overlapping
cognitive deficits observed in users of different drugs, including
working memory, inhibitory control, flexibility or decision-making
deficits [3]. In addition, some specific effects have been described
for the association between cocaine use and the parietal cortex
[4,5,6], heroin use and the temporal cortex [7], MDMA use and
occipital, hippocampus and thalamic regions [8,9], and cannabis
use and the premotor cortex [10,11]. These associations are
congruent with relatively specific neuropsychological deficits
pertaining to attention and cognitive control in cocaine users,
long-term memory in opiate users, visuospatial memory in
MDMA users, and psychomotor function in cannabis users
[3,7]. In spite of the available evidence, in vivo studies have not
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39830
been systematically conducted to look at associations between
severity of use of different drugs and brain dysfunction. In fact,
several neuroimaging studies have failed to detect such link or
have provided controversial results (reviews in [12]). These
negative findings and controversies might be linked to the impact
of relevant confounding variables. One of these is the fact that
neuroimaging studies have frequently tested drug users currently
using drugs or having brief periods of abstinence (24–48 h)
[13,14]; under these conditions, the presumed link between
lifetime drug use and brain dysfunction could be masked by
several other factors, including recent drug use or psychological
symptoms associated with withdrawal and short-term abstinence
[2]. Another key variable for consideration is the concurrent use of
multiple types of substances, which can introduce significant
confounds in the interpretation of the data.
The current study aimed to specifically address the association
between lifetime estimates of use of different types of drugs and
brain functioning (as measured by 18F-fluorodeoxyglucose Posi-
tron Emission Tomography (FDG-PET), statistically controlling
for the concurrent use of other drugs in a sample of polysubstance
users with prolonged abstinence from all drugs. Specifically, we
examined the link between lifetime estimates of amount and
duration of use of cocaine, heroin, alcohol, MDMA and cannabis
and brain metabolism (BM). Based on previous findings we
hypothesized that exposure to all substances would be significantly
associated with overlapping reductions of metabolism in frontal,
limbic, striatal and cerebellar regions, whereas cocaine and heroin
use would specifically correlate with parietal and temporal cortices
respectively.
Methods
1. Participants
Forty-nine substance dependent individuals (SDI), forty-one
men and eight women with a mean age of 32.67 years, were
recruited during their stay in an inpatient treatment program at
the centre ‘‘Proyecto Hombre’’ in Granada (Spain). This centre
provides a controlled setting for the treatment of substance use
disorders. Selection criteria for participants in this study were (i)
meeting the DSM-IV criteria for substance dependence; (ii)
absence of documented comorbid mood or personality disorders,
as assessed by clinical reports; (iii) absence of documented head
injury or neurological disorders; and (iv) to have minimum
abstinence duration from all drugs consumed (except for tobacco)
of 15 days before testing. In fact, SDI participants had overall
much longer abstinence duration (mean of 32.94, SD = 11.25
weeks); for that reason it was possible to rule out the presence of
withdrawal symptoms or brain function alterations associated with
the acute or short term effects of the drugs. None of the
participants were experiencing withdrawal symptoms as assessed
by routine medical examination or were enrolled in opioid
substitution treatments with methadone or other pharmacological
treatments (e.g., benzodiazepines) during the course of the
assessment interview/PET evaluations.
2. Testing Protocols and Procedures
This study was approved by the Human Subjects Committee of
the University of Granada. One-step Syva urine drug screens for
amphetamines, benzodiazepines, cannabis, cocaine and opiates
were conducted to confirm abstinence at time of testing.
Participants were evaluated individually in two different sessions.
During the first session, the participants were provided with
information about the study and were encouraged to ask questions
to ascertain they fully understood the rational for the study and
were clear on the details for participation. The participants then
provided written consent and were assessed with the Interview for
Research on Addictive Behaviours [15] in the ‘‘Proyecto Hombre’’
installations’’. During the second session, each patient was
accompanied by a therapist to the nuclear medicine service of
the ‘‘Virgen de las Nieves’’ hospital, where the PET neuroimaging
session took place. This second session usually took place one week
after the first session was completed.
3 Tools
3.1 Drug use information. The Interview for Research on
Addictive Behaviour [15] was used to examine the severity of drug
use. This interview evaluates, by means of a brief interview, the
quantity (average dosing), frequency (number of drug taking
episodes per month), and duration (years of duration) of the use of
different substances that can produce physical or psychological
dependence, including cocaine, heroin, alcohol, MDMA and
cannabis which were the main drugs of choice in the present study.
For every substance the participant had actually used, the
following information was requested: (i) the average dose of each
target drug taken in each episode of use (number of grams for
cocaine and heroin, number of units for alcohol, considering that
25 cl. of hard liquor (e.g., scotch) equals 2 units, while 25 cl. of
wine or beer equals 1 unit, number of pills for MDMA and
number of cigarettes for cannabis); (ii) the frequency of these
consumption episodes per month (daily, between one and three
times upon a week, once a week, between one and three times
upon a month, or once a month); and (iii) the number of years that
elapsed since the onset of use. From this information, we obtained
two indices for each of the drugs used: (i) Amount (average dose x
frequency), an index of monthly use of the drug; and (ii) Duration of
drug use, measuring number of years of exposure to the drug. The
main sociodemographic and clinical features from the sample are
displayed in Table 1.
3.2 PET image acquisition. PET scans were acquired with
an ECAT/931 scanner (Siemens CTI ECAT EXACT), at the
service of nuclear medicine centre of the hospital ‘‘Virgen de las
Nieves’’ in Granada (Spain). For each individual, we obtained 20
minute emission scans 30 minutes after the injection of one dose of
200 MBq of FDG administrated only after levels of glycemia had
been checked (they must be below 120 mg/dl) [16]. The subjects
were scanned with their eyes open and ears unplugged in a dimly
illuminated quiet room. Raw data were processed using an
iterative reconstruction technique (OSEM method: 10 iterations,
32 subsets). Images were reoriented in transaxial, coronal and
saggital planes. For the analyses reported here the reconstructed
images used had 47 axial slices each with an in-plane resolution of
2.5762.57 and a slice thickness of 3.38 mm.
4 Data Analysis
4.1 Preprocessing of PET images. PET images were
converted from DICOM to NIFTI format and were spatially
normalized to the SPM PET template (Wellcome Department of
Cognitive Neurology, London, UK) using linear (12 affine) and
non-linear normalization. An average image of all the normalized
images was obtained and this acted as a study specific PET
template. In this manner we constructed a template in the same
modality, from the same scanner as the images we wanted to
normalize. The raw PET images were then spatially normalized
with linear affine and nonlinear parameters to this study-specific
template. Visual inspection revealed this optimized spatial
normalization technique produced satisfactory spatial normaliza-
tion for the PET image of every volunteer.
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4.2 Statistical analysis. The spatially normalized PET
images were smoothed with an 8 mm3 isotropic Gaussian filter
and were statistically modeled using the General Linear Model in
SPM5. Linear regressions were used to carry out several analyses
in order to identify brain areas with a significant correlation
between uptake values and measures of the amount and duration
of cocaine, heroin, alcohol, MDMA and cannabis use. Not all
subjects used all the drugs but since virtually all participants had
regularly abused two or more substances, the analyses were
conducted on the whole group and results were interpreted in
relation to polysubstance use. In each of the analysis, we controlled
for the effects of the other substances concurrently used (e.g.,
analysis of severity of cocaine use controlled for the effects of co-
abuse of heroin, alcohol, MDMA and cannabis), age and years of
education. We report local maximum peaks that survive a voxel
threshold of p,0.001 (uncorrected for multiple comparisons,
cluster size $100 voxels). We chose to report our findings at this
threshold based on numerous similar studies of PET imaging in
drug addiction [17,18].
Results
The main results are summarized in Table 2.
1 Amount of Use
Voxel-based analyses showed negative correlations between
lifetime amount of cocaine, alcohol and cannabis use and several
brain regions. The amount of cocaine used was negatively
correlated with a cluster encompassing the left inferior parietal
lobule extending to the left postcentral gyrus (Figure 1.1). The
amount of alcohol used was negatively associated with three
clusters: one cluster included the left middle and superior temporal
cortex; a second cluster included the bilateral superior frontal
cortex extending to the left DLPFC and the right supplementary
motor area; and a third cluster included the right DLPFC
extending to the superior frontal gyrus (Figure 1.2). The amount of
cannabis use showed a negative correlation with two clusters: one
cluster included the left inferior frontal gyrus (pars triangularis)
extending to the DLPFC, and a second cluster included the right
DLPFC extending to the superior frontal cortex (Figure 1.3). We
did not find significant correlations between the amount of heroin
or MDMA use and BM measures.
2 Duration of Use
Voxel-based analyses showed negative correlations between
duration of heroin, alcohol and MDMA use and several brain
regions. Duration of heroin use showed a negative correlation with
three clusters, which encompassed the right inferior, middle and
superior temporal cortex extending to the right supramarginal and
inferior frontal gyrus (Figure 1.4). Duration of alcohol use was
negatively correlated with four clusters. One cluster included the
right inferior temporal cortex extending to the middle aspect of
this area. A second cluster included the right putamen and
pallidum. A third cluster encompassed the right precentral and
postcentral gyrus and the fourth cluster included the right fusiform
and parahippocampal gyrus (Figure 1.5). Finally, we found
negative correlations between the duration of MDMA use and
BM in three clusters: the first cluster included the left postcentral
and inferior parietal gyrus; the second cluster included the right
inferior frontal gyrus (pars triangularis) extending to the DLFPC;
and the third cluster included the right superior temporal pole
extending to the middle part of this region (Figure 1.6).
Discussion
Our findings showed that the estimates of severity of use of
heroin, alcohol, MDMA and cannabis were negatively associated
with DLPFC and temporal cortex regional metabolism in
polysubstance dependent individuals with prolonged abstinence
from all these drugs. Alcohol use was further associated with lower
metabolism in frontal premotor cortex and putamen. Further-
more, severity of stimulants use (cocaine and MDMA) was
uniquely associated with inferior parietal/postcentral cortex
metabolism. These associations were established after a prolonged
period of abstinence, and after controlling for multiple confound-
ing variables, thus surpassing the limitations of previous functional
neuroimaging studies that were not specifically designed to study
prolonged abstinence, and were confounded by important
variables, such as withdrawal related symptoms or concurrent
use of multiple substances. The associations found are in
agreement with our initial predictions, and with the neuropsycho-
logical deficits typically aligned with the chronic use of these
substances; these include reduced competency in executive
functions (related to all classes of drugs), episodic memory (mainly
observed on heroin, alcohol, MDMA and cannabis users), motor
control (alcohol and cannabis users), and visuospatial attention
(stimulants users) (see meta-analyses in [3,8,19,20]).
As expected, the estimates of amount or duration of different
classes of drugs were negatively associated with overlapping
regions within the DLPFC (BA 9, 45, 46). This region has been
linked with several of the key neuroadaptations associated with
drug addiction, including drug conditioning, loss of self-control,
and stimulus-driven compulsive behavior [2]. This finding is also
Table 1. Sociodemographic data and clinical features of the
participants.
Subjects Characteristics
Gender
Male 41
Female 8
Mean S.D. Maximum Minimum
Age (years) 32.67 8.03 53 21
Education (years) 9.73 2.34 17 5
Amount of drug usea
Substance Mean S.D. Maximum Minimum
Cocaine (g) (46) 48.69 44.83 180 0
Heroin (g) (16) 9.12 20.63 120 0
Alcohol (units) (45) 571.24 489.34 1800 0
MDMA (pills) (23) 13.41 24.31 120 0
Cannabis (cigarettes) (37) 148.57 190.64 750 0
Duration of drug use (years)
Substance Mean S.D. Maximum Minimum
Cocaine 7.95 5.95 23 0
Heroin 1.76 3.69 17 0
Alcohol 10.85 7.67 27 0
MDMA 1.40 2.28 8 0
Cannabis 8.31 8.13 29 0
Abstinence (weeks) 32.94 11.25 60 12
aAmount of monthly use of the drug calculated using the average dose (per
episode)6 frequency (per month).
doi:10.1371/journal.pone.0039830.t001
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in agreement with results from several neuropsychological studies
showing cognitive deficits on working memory, planning or
inhibition processes, which are associated with DLPFC function-
ing, across users of several drugs [3]. We also found negative
associations between estimates of duration of heroin, alcohol, and
MDMA use and regional metabolism on partially overlapping
sections of the temporal cortex. These associates may substantiate
the links between the intensity and duration of involvement with
these drugs and the degree of memory attrition, which has been
observed in longitudinal studies with users of these substances
[21,22]. It is worth mentioning that duration of heroin use was
shorter to that of cocaine and alcohol use; however, previous brain
structural findings indicate that duration of heroin use is a critical
factor leading to brain damage, even in users with periods of use
below five years [23]. Surprisingly, we failed to find significant
associations between the severity of the substances used and
overlapping limbic, striatal and cerebellar regions but this result
could be explained from the fact that these regions play a greater
role during current use and short-term abstinence [24]. In
addition, we found relatively specific negative correlations between
amount of cocaine use and regional metabolism in the inferior
parietal cortex, and between alcohol duration and regions involved
in motor programming and control (frontal precentral and
putamen). The link between cocaine use and parietal dysfunction
has been observed on previous functional imaging studies during
cognitive challenges of attention and executive control [6,25,26].
The link between alcohol use and precentral and basal ganglia
dysfunction is in agreement with structural imaging findings
showing that function of these regions is significantly reduced in
alcohol users compared to other forms of addiction [27].
Additional evidence comes from volumetric studies which
associated volumetric measures of these regions and deficient
motor skills in alcoholics [28]. These more specific findings could
be used to design tailored interventions aimed to address specific
aspects of frontal-subcortical executive functions in different
profiles of substance abusers.
An important implication of this study is the fact that the link
between severity of drug use and BM is still observable in
substance abusers with prolonged periods of abstinence (an
average of eight months in this sample). Therefore, quantity and
duration of drug use may still be affect brain functioning after
several months of successful cessation of drug use. This is
particularly relevant in view of recent findings indicating that
certain patterns of brain dysfunction can reliably predict mid-term
and long-term relapse. Permanent brain alterations may also have
important repercussions for the rehabilitation of SDI, since these
alterations can affect the ability of SDI to assimilate the contents
and participate in the activities of the rehabilitation programs
[29,30]. In fact, preliminary evidence suggests that cognitive
rehabilitation techniques, such as errorless learning may be
successful in compensating chronic cognitive deficits in substance
abusers [31]. Thus, the brain networks impacted by severity of
drug abuse can play a central role in clinical outcome and relapse
and should become priority targets for therapeutic interventions.
Several possible limitations of our study should be considered
and addressed by future research. Our findings were not obtained
in ‘‘pure’’ users of each of the substances but in mostly
polysubstance users. Although this limitation is inherent to the
clinical literature on addiction (i.e., ‘‘pure’’ users of one single drug
are quite rare among substance abusers enrolled in treatment
programs), we attempted to control for the co-abuse of other drugs
using statistics. A related confounding variable was the use of
nicotine, which is ubiquitous among drug users but was not
specifically assessed or controlled for. Furthermore, due to the use
Table 2. Relation between severity of drug use and PET uptake.
Substancee Voxels-Based Analysis BA KE T MNI
Amount
Cocaine Parietal Inf L 40 176 3.98 258 238 54
Alcohol Temporal Mid L 21 267 4.04 266 22 210
Frontal Sup L 9 308 3.96 220 30 36
Frontal Sup R 6 365 3.73 22 2 60
Frontal Mid R 46 372 3.82 26 22 34
Cannabis Frontal Inf Tri L 45 355 4.40 244 22 30
Frontal Mid R 46 125 4.02 24 48 28
Duration
Heroin Frontal Mid R 46 876 3.77 44 36 34
Temporal Inf R 20 257 4.58 62 216 232
Temporal Sup R 22 1090 4.19 66 244 20
Alcohol Temporal Inf R 20 238 4.22 64 216 230
Putamen R 472 3.71 20 22 8
Precentral R 6 274 3.67 50 2 34
Fusiform R 20 299 3.65 30 26 240
MDMA Postcentral L 40 131 3.73 228 240 48
Frontal Inf Tri R 45 139 3.67 44 34 20
Temporal Pole Sup R 20 561 3.67 32 12 230
Voxel-based analyses at p,0.001 (uncorrected, cluster size .100 voxels). Labels were obtained using the aal toolbox [32]. Broadmann areas were obtained using
MRICron (Rorden and Brett, 2000). KE indicate the number of voxels included in the cluster. Stereotaxic coordinates are those listed in SPM5. Inf, inferior; Sup, superior; L,
left; R, right; Supp, supplementary; Mid, middle; Orb, orbitalis.
doi:10.1371/journal.pone.0039830.t002
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of a correlational design, this study cannot yield conclusions about
cause-effect relationships between the use of drug and resting BM.
However, given the agreement of our results with both resting
state PET, activation PET/fMRI and addiction neuropsychology
studies, we could hypothesize that, at least in part, the alterations
observed in this population could be due to the quantity and
duration related effects of the consumption of the substances under
consideration in this study.
One last point to consider is that our findings could be due to
premorbid brain alterations or the results of the interaction
between the premorbid alterations and the neurotoxic effects of
drug use. This question should be addressed through longitudinal
designs. A related limitation is that no comparison with a healthy
control database was performed. As we argued before, a healthy
control group was not needed to test the main predictions of our
study; however, the lack of controls has stopped us from making
any assumption about the direction of these findings in relation to
the healthy population.
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Figure 1. Areas of reduced metabolism predicted by the amount or duration of drug use: (1) amount of cocaine, (2) amount of alcohol, (3)
amount of cannabis (4) duration of heroin (5) duration of alcohol and (6) duration of MDMA. Areas of reduced metabolism are superimposed on a T1
weighted MRI image in MRICRON. MNI coordinates are shown underneath each panel.
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